TB-500 (Thymosin Beta-4)
Overview
Thymosin Beta-4 is a 43-amino acid actin-sequestering protein involved in cell migration, differentiation, and tissue repair. It promotes wound healing by upregulating cell-building proteins such as actin and laminin, facilitating cell migration to sites of injury. TB-500 also has anti-inflammatory properties mediated through NF-kB pathway modulation.
Key Research Findings
Accelerated dermal wound repair and corneal epithelial healing in clinical studies. Phase II trials showed improved cardiac function post-myocardial infarction (RegeneRx Biopharmaceuticals).
Subcutaneous injection
In Clinical Trials
Interested in TB-500 (Thymosin Beta-4)?
Find a verified provider experienced with TB-500 (Thymosin Beta-4) protocols in your area. All providers are credentialed and use compliant sourcing.
Find a TB-500 (Thymosin Beta-4) ProviderRelated Peptides
BPC-157
Research PhaseA synthetic gastric pentadecapeptide derived from a protein found in human gastric juice. BPC-157 promotes angiogenesis and the expression of growth factors including VEGF, EGF, and NO-mediated pathways. It has demonstrated cytoprotective and wound-healing properties across multiple tissue types in preclinical models, including tendon, muscle, ligament, and gastrointestinal mucosa.
GHK-Cu
Research PhaseA naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) found in human plasma, saliva, and urine. GHK-Cu activates tissue remodeling by stimulating collagen synthesis, glycosaminoglycan production, and angiogenesis while suppressing fibrinogen synthesis. It modulates the activity of matrix metalloproteinases and influences over 4,000 genes related to tissue repair.
DSIP (Delta Sleep-Inducing Peptide)
Research PhaseA naturally occurring nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) originally isolated from cerebral venous blood of rabbits during induced sleep. DSIP modulates sleep architecture by promoting delta wave (slow-wave) sleep through interactions with the GABAergic system and hypothalamic sleep centers. It also exhibits stress-protective, analgesic, and neuromodulatory properties.
Pentosan Polysulfate (Elmiron)
FDA ApprovedA semi-synthetic sulfated polysaccharide derived from beechwood hemicellulose with structural similarities to glycosaminoglycans. Pentosan polysulfate replenishes the defective glycosaminoglycan layer of the bladder urothelium in interstitial cystitis, reducing urothelial permeability to irritants. It also exhibits anti-inflammatory, anticoagulant, and fibrinolytic properties through inhibition of complement activation and mast cell histamine release.